Oxurion NV (EBR:OXUR)
Belgium · Delayed Price · Currency is EUR 0.0038
-0.0002 (-5.00%)
Apr 30, 2026, 4:05 PM CET
Oxurion NV Market Cap
Oxurion NV has a market cap or net worth of €337.03 thousand as of May 1, 2026. Its market cap has decreased by -15.44% in one year.
Market Cap
337.03K
Enterprise Value
11.16M
Revenue
2.00K
Ranking
n/a
PE Ratio
0.01
Stock Price
€0.00
Market Cap Chart
Since July 7, 2006, Oxurion NV's market cap has decreased from 100.46M to 337.03K, a decrease of -99.66%. That is a compound annual growth rate of -24.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 337.03K | -25.22% |
| Dec 31, 2025 | 450.71K | -41.17% |
| Dec 31, 2024 | 766.13K | -73.79% |
| Dec 29, 2023 | 2.92M | -62.57% |
| Dec 30, 2022 | 7.81M | -88.99% |
| Dec 31, 2021 | 70.93M | -27.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 43.06B |
| argenx SE | 41.39B |
| Financière de Tubize | 8.71B |
| Onward Medical | 184.25M |
| Hyloris Pharmaceuticals | 149.52M |
| European Medical Solutions | 20.91M |
| Celyad Oncology | 14.28M |
| BioSenic | 1.57M |